Ductal carcinoma in situ of the breast with apocrine characteristics: case report.
Keywords:
In situ ductal carcinoma, apocrine carcinoma, van Nuys scale, estrogen receptors, progesterone receptors, androgen receptors, GCDFP15Abstract
We present the case of a 69 year old female diagnosed with a ductal in situ carcinoma of the breast. The tumor had apocrine differentiation and a high nuclear grade. The clinical presentation corresponded to microcalcifications detected on mammography, which were histologically patent in the form of comedo type necrosis. The aforementioned apocrine differentiation was reassured using the aid of immunohistochemistry. The biopsy was an excisional biopsy, but due to positive quirurgical margins, the patient was later reintervened for total mastectomy.
References
2. Asirvatham, Jaya Ruth. Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls. Arch Pathol Lab Med. 2016 Oct;140 (10):1045-1051.
3. Cho Nariya, Moon Woo Kyung. Digital Mammography Guided Skin Marking for Sonographically Guided Biopsy Suspicious of Malignancy. American Journal of Roentgenology. 2009;192: W132-W136.
4. Fuehrer, Neil et al. Atypical Apocrine Adenosis of the Breast: Long-Term Follow Up in 37 Patients. Arch Pathol Lab Med. 2012 Feb;136 (2):179-182.
5. Gilleard, Onur et al. The Significance of the Van Nuys Prognostic Index in the Management of Ductal Carcinoma in Situ. World Journal of Surgical Oncology. 2008;(6):61.
6. Goldstein, Neal S., O´Malley, Barbara A. Cancerization of Small Ectatic Ducts of the Breast by Ductal Carcinoma In Situ Cells With Apocrine Snouts: a Lesion Associated With Tubular Carcinoma. American Journal of Clinical Pathology.1997. Vol. 107: N. 105. P. 561-566.
7. Gucalp, Al et al. Phase II Trial of Bicalutamide in Patients With Androgen Receptor Positive, Estrogen Receptor Negative Metastasic Breast Cancer. Clin Cancer Res 2013 Oct 1; 19 (19):5505-5512.
8. Hickey. T.E et al. Minireview: The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene? Molecular Endocrinology,2012;26(8):1252-1267.
9. Jones, Chris et al. Molecular Cytogenetic Comparison of Apocrine Hyperplasia and Apocrine Carcinoma of the Breast. American Journal of Pathology, Vol. 158, No. 1, January 2001. P. 207-214.
10. Jung Shin, Hee et al. BI-RADS Descriptors for Mammographically Detected Microcalcifications Verified by Histopathology After Needle Localized Open Breast Biopsy. American Journal of Roentgenology. 2010;195: 1466-1471.
11. Martínez-Galvez, María et al. Biopsia guiada por arpón de lesiones de mama no palpables y no ecovisibles: una modificación técnica. Madrid, España. Editorial Elsevier. Nov 2013. Tomado de www.elsevier.es.
12. O´Malley F.P, Bane, A. An update on apocrine lesions of the breast. Histopathology. 2008, 52: 3–10.
13. Renshaw, Andrew A. Predicting Invasion in the Excision Specimen from Breast Core Needle Biopsy Specimens with Only Ductal Carcinoma In Situ. Arch Pathol Lab Med. 2002 Jan;126 (1):39-41.
14. Rosen, Paul P., Hoda, Syed A., Koerner C. Frederick, Brogi, Edi. Rosen´s Breast Pathology. 4ta edición. Lippincott Williams. Philadelphia, USA:2014. P. 1399.
15. Scawn, Richard et al. Morphologic Spectrum of Estrogen Receptor-Negative Breast Carcinoma. Arch Pathol Lab Med. 2002 Mar;126 (3):325-330.
16. Schnitt, Stuart J., Collins, Laura C. Biopsy Interpretation of the Breast. 2da edición. Lippincott Williams. Piladelphia, USA: 2013. P.540.
17. Visscher, Daniel W. Apocrine Ductal Carcinoma In Situ Involving a Sclerosing Lesions With Adenosis: Report of a Case. Arch Pathol Lab. Med. 2009. Nov; 133 (11). P. 1817-1821.
Downloads
Published
Issue
Section
License
The intellectual property of accepted works belongs to their authors, however access to them is totally open and free, so they can be reproduced totally or partially with the only limitation of recognizing the authorship and the source of publication (Revista Medicina Legal de Costa Rica), as long as said exploitation does not have commercial character.
